Why Broadcom's $230 Billion AI Bet Is Really an Anthropic Bet
Jim Cramer called it the jaw-drop number of the year. But Broadcom's forward AI guidance hides a single-customer dependency so concentrated it makes NVIDIA's book look diversified. The stock you can't buy may be the only one that matters.
The Number No One Can Ignore
Hock Tan dropped a guidance figure on Tuesday night that Jim Cramer called the jaw-drop statement of the year. Broadcom expects AI semiconductor revenue to reach approximately $115 billion in fiscal 2027. Then double again in fiscal 2028 to $230 billion.
The market sold it anyway. AVGO closed at $367.24 Wednesday and traded at $352.04 by Thursday midday, down 4 percent. The stock is down 6 percent over the past month despite being up 24 percent year to date.
Investors are not questioning the math. They are questioning the structure underneath it. Broadcom’s own Q3 8-K filing lists dependence on a limited number of significant customers for AI semiconductor demand as a risk factor. Tan just named those customers and revealed the exposure is thinner than most people realize.
Who Actually Buys the Chips
Tan gave the customer-by-customer gigawatt roadmap on the earnings call. Anthropic is deploying one gigawatt of Ironwood in 2026, another five gigawatts of TPU v8i in 2027, and has line of sight to an incremental 10 gigawatts in 2028. Tan said Anthropic is on track to become Broadcom’s largest XPU customer in 2027 and sustain that position in 2028.
OpenAI is second, with 1.3 gigawatts of Jalapeno planned for 2027 and line of sight for over 5 gigawatts in 2028. Google, Meta, and two unnamed customers round out the six.
The concentration is striking. Two companies alone account for the vast majority of the guided growth. Everything beyond that is speculation wrapped in line-of-sight language.
The Stock You Cannot Buy
Here is what Cramer nailed and everyone else is underplaying. Anthropic is private. If you own Broadcom because you believe in the $230 billion fiscal 2028 number, you are effectively long an IPO that has not been filed. You have no direct way to express that view. You cannot buy Anthropic shares on any exchange.
An Anthropic IPO becomes the clearing event. It validates the entire chain. Until then, AVGO holders are carrying single-customer risk with no exit ramp other than waiting for quarterly updates.
The market priced this realization into the stock Thursday. Cramer’s framing was blunt on CNBC’s Squawk on the Street. He said Anthropic is the stock you cannot buy. For AVGO holders, it may be the only one that matters.
Why NVIDIA Looks Different
NVIDIA sits on the other side of this same customer base. Jensen Huang’s strategic partnership with OpenAI to deploy at least 10 gigawatts of NVIDIA systems, combined with Anthropic’s scaling on NVIDIA infrastructure with an initial 1 gigawatt commitment, gives NVIDIA a more diversified frontier-lab book.
The numbers tell the story. NVIDIA’s Q2 FY2027 revenue was $96.22 billion, up 105.8 percent year over year. Q3 guidance of $108 billion spreads that concentration across more customers and more geographies. The market treated it accordingly Thursday. NVDA traded up 2 percent to $227.88 while Broadcom sold off.
NVIDIA’s customer base is wider. Broadcom’s is deeper on fewer names. Both are betting the farm on the same AI capex cycle. The difference is who absorbs the shock if one of those names stumbles.
The Fraud Distillation Wrecking Ball
One more wrinkle worth pricing in before you buy the guidance. Anthropic disclosed that foreign AI labs used 24,000 fraudulent accounts to distill its Claude models. Model-distillation risk is now a real line item for any lab preparing to go public.
This matters beyond compliance. It raises questions about how much of Anthropic’s training data is actually clean, how defensible its moat is, and whether the company’s path to profitability survives regulatory scrutiny. Any S-1 filing will have to address this head-on. Investors reading the risk factors will be looking for answers about data provenance and the cost of defending against extraction attacks.
What Happens Next
If you own Broadcom because you believe in the $230 billion fiscal 2028 AI number, you are making a bet on two things. First, that Anthropic files an S-1 and executes the IPO without significant delay orvaluation haircut. Second, that Broadcom delivers on the roadmap with no major customer defections or execution missteps.
Watch for two catalysts. Any formal Anthropic S-1 filing would be the first real test of whether the market believes the guidance. Broadcom’s fiscal Q4 report scheduled for December 9, 2026, is where the customer mix behind that $115 billion FY27 setup gets its first real update.
The stock trade is simple. If Anthropic moves toward IPO, AVGO reprices higher. If the filing delays or gets scoped down, the guidance looks like wishful thinking and the multiple compresses. Cramer called it Anthropic or bust. The price action Thursday suggests the market heard him.
The Bigger Picture
This is not just a Broadcom story. It is a story about how concentrated the AI infrastructure buildout has become. Six customers. Two of them carry the bulk of the guided revenue. The rest are line-of-sight promises.
Custom silicon is supposed to be the next phase of the AI capex cycle. Companies want tailored chips, not off-the-shelf GPUs. Broadcom is winning that bet right now. But the bet only pays off if the customers behind it survive, scale, and eventually go public.
NVIDIA has insurance through diversification. Broadcom does not. That is the risk Cramer identified and the reason the market sold the stock despite the guidance being technically stronger than anyone expected.